[Federal Register Volume 79, Number 20 (Thursday, January 30, 2014)]
[Notices]
[Page 4974]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-01785]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Halo Pharmaceutical, Inc.

    By Notice dated August 14, 2013, and published in the Federal 
Register on August 20, 2013, 78 FR 51210, Halo Pharmaceutical, Inc., 30 
North Jefferson Road, Whippany, New Jersey 07981, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the following basic classes of controlled 
substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Dihydromorphine (9145).....................  I
Hydromorphone (9150).......................  II
------------------------------------------------------------------------

    Dihydromorphine is an intermediate in the manufacture of 
Hydromorphone and is not for commercial distribution.
    The company plans to manufacture Hydromorphone for sale to other 
manufacturers and to manufacture other controlled substances for 
distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a), and determined that the registration 
of Halo Pharmaceutical, Inc., to manufacture the listed basic classes 
of controlled substances is consistent with the public interest at this 
time. DEA has investigated Halo Pharmaceutical, Inc., to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed.

    Dated: January 15, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2014-01785 Filed 1-29-14; 8:45 am]
BILLING CODE 4410-09-P